Effects of Cancer Chemotherapy on Sulphydryl Levels in Rat Tissues
Author Information
Author(s): G. Calcutt
Primary Institution: Department of Cancer Research, Mount Vernon Hospital and the Radium Institute
Hypothesis
The study investigates how cancer chemotherapy agents affect sulphydryl levels in normal rat tissues.
Conclusion
The study found that different chemotherapy agents have varying effects on sulphydryl levels in different rat tissues.
Supporting Evidence
- The study measured sulphydryl levels in liver, kidney, lungs, intestine, brain, thymus, Peyer's patches, spleen, and bone marrow.
- Results showed that the effects of chemotherapy agents varied significantly across different tissues.
- Chlorambucil caused a notable decrease in protein bound sulphydryl levels in the liver.
- Merophan showed significant effects on brain sulphydryl levels, raising concerns about potential brain damage.
- Bone marrow exhibited high protein bound sulphydryl levels, indicating its sensitivity to alkylating agents.
Takeaway
This study looked at how cancer drugs change certain chemicals in rats' bodies, and found that different drugs affect different parts of the body in different ways.
Methodology
The study involved measuring sulphydryl levels in various rat tissues before and after administering single doses of five different chemotherapy agents.
Limitations
The study was limited by the availability of rat tissues and the number of compounds examined.
Participant Demographics
Female August strain rats, aged 12 to 14 weeks, weighing 125-150 g.
Want to read the original?
Access the complete publication on the publisher's website